Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Cue Biopharma (CUE) Revenue (2018 - 2025)

Historic Revenue for Cue Biopharma (CUE) over the last 8 years, with Q3 2025 value amounting to $2.1 million.

  • Cue Biopharma's Revenue fell 3558.15% to $2.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $7.1 million, marking a year-over-year decrease of 2551.41%. This contributed to the annual value of $9.3 million for FY2024, which is 6916.21% up from last year.
  • According to the latest figures from Q3 2025, Cue Biopharma's Revenue is $2.1 million, which was down 3558.15% from $3.0 million recorded in Q2 2025.
  • In the past 5 years, Cue Biopharma's Revenue registered a high of $8.3 million during Q4 2021, and its lowest value of $26000.0 during Q2 2022.
  • Moreover, its 5-year median value for Revenue was $1.7 million (2024), whereas its average is $1.9 million.
  • As far as peak fluctuations go, Cue Biopharma's Revenue plummeted by 9905.07% in 2022, and later soared by 521538.46% in 2023.
  • Over the past 5 years, Cue Biopharma's Revenue (Quarter) stood at $8.3 million in 2021, then crashed by 98.17% to $151000.0 in 2022, then soared by 1105.96% to $1.8 million in 2023, then fell by 13.45% to $1.6 million in 2024, then skyrocketed by 36.36% to $2.1 million in 2025.
  • Its Revenue stands at $2.1 million for Q3 2025, versus $3.0 million for Q2 2025 and $421000.0 for Q1 2025.